BioMarin Pharmaceutical Inc.
DE ˙ DB ˙ US09061G1013
46,59 € ↑0,90 (1,97%)
2026-06-04
DEL PRIS
SecurityDE:BM8 / BioMarin Pharmaceutical Inc.
InstitutionStifel Financial Corp
Latest Disclosed Ownership39,149 shares
Latest Disclosed Value $ 2,211,518
Stifel Financial Corp reports 1.95% decrease in ownership of BM8 / BioMarin Pharmaceutical Inc.

On May 12, 2026 - Stifel Financial Corp filed a 13F-HR form disclosing ownership of 39,149 shares of BioMarin Pharmaceutical Inc. (DE:BM8) valued at $1,878,369 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 39,929 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of -1.95% during the quarter. The current value of the position is $1,823,952 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 39,149 -780 -1.95 2,212 -6.79 0.0005
2026-02-13 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 39,929 7,476 23.04 2,373 35.00 0.0021
2025-11-12 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 32,453 -1,037 -3.10 1,758 -4.56 0.0016
2025-08-14 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 33,490 -5,792 -14.74 1,841 -33.68 0.0018
2025-05-14 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 39,282 7,385 23.15 2,777 32.44 0.0030
2025-02-13 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 31,897 1,360 4.45 2,097 -2.33 0.0022
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 30,537 -13,487 -30.64 2,146 -40.78 0.0023
2024-08-13 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 44,024 124 0.28 3,625 -5.48 0.0041
2024-05-14 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 43,900 -5,776 -11.63 3,834 -19.94 0.0044
2024-02-12 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 49,676 4,468 9.88 4,790 19.75 0.0060
2023-11-13 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 45,208 7,043 18.45 4,000 20.89 0.0056
2023-08-14 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 38,165 -866 -2.22 3,308 -12.83 0.0045
2023-05-12 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 39,031 -4,609 -10.56 3,795 -15.97 0.0054
2023-02-13 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 43,640 1,669 3.98 4,516 26.89 0.0068
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 41,971 2,506 6.35 3,559 8.84 0.0058
2022-08-15 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 39,465 -6,527 -14.19 3,270 -7.78 0.0051
2022-05-13 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 45,992 -84,284 -64.70 3,546 -69.19 0.0048
2022-02-14 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 130,276 -9,351 -6.70 11,509 6.64 0.0152
2021-11-15 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 139,627 -22,967 -14.13 10,792 -20.45 0.0158
2021-08-13 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 162,594 -198 -0.12 13,567 10.36 0.0203
2021-05-14 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 162,792 -14,313 -8.08 12,293 -20.85 0.0203
2021-02-12 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 177,105 7,645 4.51 15,531 20.46 0.0277
2020-11-16 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 169,460 18,870 12.53 12,893 -30.58 0.0265
2020-08-14 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 150,590 -7,183 -4.55 18,573 37.06 0.0427
2020-05-14 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 157,773 32,824 26.27 13,551 26.01 0.0374
2020-02-13 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 124,949 3,490 2.87 10,754 30.38 0.0224
2019-11-19 2019-09-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 121,459 20,352 20.13 8,248 -6.52 0.0210
2019-11-13 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 121,570 20,463 8,256 4,627.9018
2019-08-14 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 101,107 30,735 43.68 8,823 38.66 0.0228
2019-05-14 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 70,372 25,012 55.14 6,363 61.17 0.0180
2019-02-13 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 45,360 5,076 12.60 3,948 1.57 0.0128
2018-11-13 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 40,284 4,666 13.10 3,887 16.03 0.0111
2018-08-14 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 35,618 26,197 278.07 3,350 343.71 0.0103
2018-05-11 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 9,421 5,103 118.18 755 97.64 0.0024
2018-02-14 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,318 -730 -14.46 382 -18.72 0.0012
2017-11-13 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,048 -876 -14.79 470 -12.80 0.0016
2017-08-14 2017-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,924 732 14.10 539 19.25 0.0020
2017-05-10 2017-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,192 -2,291 -30.62 452 -26.74 0.0017
2017-02-16 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 7,483 1,315 21.32 617 8.63 0.0026
2016-11-15 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,168 2,424 64.74 568 94.52 0.0026
2016-08-17 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,744 -1,349 -26.49 292 -30.48 0.0014
2016-05-16 2016-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,093 1,600 45.81 420 14.75 0.0022
2016-03-21 2015-12-31 13F/A-2 BIOMARIN PHARMACEUTICAL COM 09061G101 3,493 3,493 366 0.0019
2016-02-26 2015-12-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 3,493 0 366 0.0019
2016-02-16 2015-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,493 785 0.0036
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.